Healthcare [ 13/13 ] | Diagnostics & Research [ 77/164 ]
NASDAQ | Common Stock
Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China.
It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services.
The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors.
In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma.
Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide.
Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 12, 22 | -2.45 Decreased by -5.48 K% | -0.22 Decreased by -1.01 K% |
| Aug 26, 22 | -0.35 Decreased by -1.03 K% | -0.03 Decreased by -1.07 K% |
| Jun 2, 22 | -0.30 Decreased by -74.53% | -0.15 Decreased by -97.80% |
| Mar 29, 22 | -0.27 Decreased by -174.90% | -0.04 Decreased by -572.13% |
| Nov 30, 21 | -0.04 Increased by +37.29% | -0.04 Decreased by -13.44% |
| Aug 24, 21 | -0.03 Increased by +83.74% | -0.03 Decreased by -3.34% |
| May 24, 21 | -0.17 Decreased by -28.30% | -0.10 Decreased by -70.00% |
| Mar 25, 21 | -0.10 | -0.08 Decreased by -25.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 22 | 137.75 M Decreased by -1.95% | -234.67 M Decreased by -155.58% | Decreased by -170.36% Decreased by -160.66% |
| Mar 31, 22 | 146.86 M Increased by +9.65% | -162.69 M Decreased by -122.19% | Decreased by -110.78% Decreased by -102.64% |
| Dec 31, 21 | 146.86 M Increased by +9.65% | -162.69 M Decreased by -122.19% | Decreased by -110.78% Decreased by -102.64% |
| Sep 30, 21 | 152.54 M Increased by +36.24% | -128.97 M Decreased by -168.71% | Decreased by -84.55% Decreased by -97.23% |
| Jun 30, 21 | 140.49 M Increased by +38.09% | -91.82 M Increased by +96.76% | Decreased by -65.36% Increased by +97.65% |
| Mar 31, 21 | 133.94 M Increased by +74.31% | -73.22 M Increased by +36.58% | Decreased by -54.67% Increased by +63.62% |
| Dec 31, 20 | 133.94 M Increased by +30.12% | -73.22 M Increased by +45.68% | Decreased by -54.67% Increased by +58.25% |
| Sep 30, 20 | 111.96 M Increased by +37.64% | -48.00 M Increased by +82.49% | Decreased by -42.87% Increased by +87.28% |